Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Vyriad Announces Collaboration with Merck KGaA and Pfizer to Evaluate Voyager-V1, Avelumab

americanpharmaceuticalreviewJuly 24, 2018

Tag: Vyriad , Merck KGaA

PharmaSources Customer Service